Schizophrenia Trial, Recruiting NCT05074732 Sponsor: Health Service Executive, Ireland Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05074732
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were admitted to the National Forensic Mental Health Service (NFMHS) in Ireland at any point from 1st December 2019 until 7 years after the service moves to its new location at Portrane, North Dublin, Ireland.

Who may not be able to join:

  • There are no listed exclusion criteria — the trial aims to include all adults admitted to the NFMHS during the specified time period, regardless of how long their stay was.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mary Davoren, M.D., Trinity College University of Dublin

Phone: 0035312157401

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Health Service Executive, Ireland
Registry
ClinicalTrials.gov
Start date
1 December 2019
Est. completion
31 December 2025

Where this trial is recruiting

🇮🇪 Ireland

Primary endpoints

Length of stay in the secure forensic hospital setting.; Recovery from psychosis; Reduction in violence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov